ENBIO Co (352940) Fair Value & Analysis
Basic Materials · KR · Market cap 21.9B KRW
Fair value as of: Jul 22, 2026
From 21 valuation models · updated 19 days ago
Share price −1.1% over the past month.
A solid business, but screening 21% overvalued on our models.
What matters now
- Solid but not exceptional quality (50/100) and above fair value, neither a clear bargain nor a standout compounder.
- Our model range runs from 1,182 KRW (bear) to 1,970 KRW (bull), base 1,576 KRW. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 50/100 (solid quality) with high evidence: the data supports the verdict.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.
How to read this chart
60‑month range 1,984 KRW – 12,900 KRW · fair‑value band 1,182 KRW – 1,970 KRW · the 1,992 KRW price screens above the 1,576 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 22, 2026.
Analysis
ENBIO Co (352940) currently trades at 1,992 KRW, while our model-based Fair Value estimate is 1,576 KRW, implying the stock looks roughly 20.9% overvalued today. The Quality Score stands at 50/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, ENBIO Co generated revenue of 34.3B KRW at a net margin of 2.3%. Revenue grew 2.2% year over year. It earns a return on equity of 1.8%. Net debt stands at 10.4B KRW. Fundamentals as of Jul 22, 2026
Our scenario range runs from 1,182 KRW (bear case) to 1,970 KRW (bull case); at 1,992 KRW, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 29% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -13% fair-value upside, at -21%, 352940 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 21 models by family
Widest divergence: Asset-Based (2,611 KRW) versus Earnings-Based (666.05 KRW). Highest evidence: Growth DCF (80).
Notify me when 352940 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 49 · Market factors (momentum, volatility) 42
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
ENBIO Co., Ltd. manufactures and sells pesticides and fertilizers in South Korea. The company provides lime sulfur, an eco-friendly crop protection agent containing sulfur; and Indoema, a broad-spectrum insecticide. It also offers disinfectant, pesticides, herbicides, growth regulator, for lawn, and trace element complex.
Full company description
ENBIO Co., Ltd. manufactures and sells pesticides and fertilizers in South Korea. The company provides lime sulfur, an eco-friendly crop protection agent containing sulfur; and Indoema, a broad-spectrum insecticide. It also offers disinfectant, pesticides, herbicides, growth regulator, for lawn, and trace element complex. The company was founded in 1997 and is headquartered in Gunpo-si, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
ENBIO Co reported revenue of 34.0B KRW in FY2025 versus 33.5B KRW in FY2021, a compound +0.4%/yr. Reported net income was 1.0B KRW in FY2025, compounding −33.8%/yr from FY2021.
352940 screens 21% overvalued. Compare with Corteva, Inc →
Peer Group
Agricultural Inputs · 179 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Agricultural Inputs median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Corteva, Inc CTVA | $86.07 | $27.81 | -68% |
| Nutrien Ltd NTR | C$94.23 | C$81.69 | -13% |
| Qinghai Salt Lake Industry Co 000792 | ¥24.93 | ¥21.26 | -15% |
| CF Industries Holdings CF | $119.19 | $161.00 | +35% |
| SABIC Agri-Nutrients Company 2020 | 122.90 SAR | 127.31 SAR | +4% |
| Yara International ASA YAR | kr 451.30 | kr 67.25 | -85% |
| Yunnan Yuntianhua Co 600096 | ¥30.17 | ¥42.12 | +40% |
| Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 | ¥42.59 | ¥38.01 | -11% |
| Coromandel International Limited COROMANDEL | ₹2,034 | ₹1,129 | -44% |
| UPL Limited UPL | ₹594.75 | ₹387.06 | -35% |
Compare ENBIO Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is ENBIO Co (352940) overvalued or undervalued?
What is the fair value of 352940?
What is the quality score of 352940?
What is the revenue of ENBIO Co (352940)?
What is the net profit margin of 352940?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track ENBIO Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.